Identification of cell type specific ACE2 modifiers by CRISPR screening.
dc.contributor.author | Sherman, EJ | |
dc.contributor.author | Mirabelli, C | |
dc.contributor.author | Tang, VT | |
dc.contributor.author | Khan, TG | |
dc.contributor.author | Leix, K | |
dc.contributor.author | Kennedy, AA | |
dc.contributor.author | Graham, SE | |
dc.contributor.author | Willer, CJ | |
dc.contributor.author | Tai, AW | |
dc.contributor.author | Sexton, JZ | |
dc.contributor.author | Wobus, CE | |
dc.contributor.author | Emmer, BT | |
dc.contributor.editor | Horner, Stacy M | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2024-10-28T18:30:13Z | |
dc.date.available | 2024-10-28T18:30:13Z | |
dc.date.issued | 2022-01-01 | |
dc.identifier.issn | 1553-7366 | |
dc.identifier.issn | 1553-7374 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/35231079 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/195387 | en |
dc.description.abstract | SARS-CoV-2 infection is initiated by binding of the viral spike protein to its receptor, ACE2, on the surface of host cells. ACE2 expression is heterogeneous both in vivo and in immortalized cell lines, but the molecular pathways that govern ACE2 expression remain unclear. We now report high-throughput CRISPR screens for functional modifiers of ACE2 surface abundance. In liver-derived HuH7 cells, we identified 35 genes whose disruption was associated with a change in the surface abundance of ACE2. Enriched among these ACE2 regulators were established transcription factors, epigenetic regulators, and functional networks. We further characterized individual HuH7 cell lines with disruption of SMAD4, EP300, PIAS1, or BAMBI and found these genes to regulate ACE2 at the mRNA level and to influence cellular susceptibility to SARS-CoV-2 infection. Orthogonal screening of lung-derived Calu-3 cells revealed a distinct set of ACE2 modifiers comprised of ACE2, KDM6A, MOGS, GPAA1, and UGP2. Collectively, our findings clarify the host factors involved in SARS-CoV-2 entry, highlight the cell type specificity of ACE2 regulatory networks, and suggest potential targets for therapeutic development. | |
dc.format.medium | Electronic-eCollection | |
dc.language | eng | |
dc.publisher | Public Library of Science (PLoS) | |
dc.relation.haspart | ARTN e1010377 | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Angiotensin-Converting Enzyme 2 | |
dc.subject | COVID-19 | |
dc.subject | Cell Line | |
dc.subject | Clustered Regularly Interspaced Short Palindromic Repeats | |
dc.subject | Humans | |
dc.subject | SARS-CoV-2 | |
dc.subject | Spike Glycoprotein, Coronavirus | |
dc.title | Identification of cell type specific ACE2 modifiers by CRISPR screening. | |
dc.type | Article | |
dc.identifier.pmid | 35231079 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/195387/2/Identification of cell type specific ACE2 modifiers by CRISPR screening.pdf | |
dc.identifier.doi | 10.1371/journal.ppat.1010377 | |
dc.identifier.doi | https://dx.doi.org/10.7302/24582 | |
dc.identifier.source | PLoS pathogens | |
dc.description.version | Published version | |
dc.date.updated | 2024-10-28T18:30:10Z | |
dc.identifier.orcid | 0000-0001-5645-4966 | |
dc.identifier.orcid | 0000-0002-6877-450X | |
dc.identifier.orcid | 0000-0002-9244-5888 | |
dc.identifier.orcid | 0000-0001-5286-0924 | |
dc.identifier.orcid | 0000-0001-7365-1021 | |
dc.identifier.volume | 18 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | e1010377 | |
dc.identifier.name-orcid | Sherman, EJ | |
dc.identifier.name-orcid | Mirabelli, C | |
dc.identifier.name-orcid | Tang, VT | |
dc.identifier.name-orcid | Khan, TG | |
dc.identifier.name-orcid | Leix, K | |
dc.identifier.name-orcid | Kennedy, AA | |
dc.identifier.name-orcid | Graham, SE | |
dc.identifier.name-orcid | Willer, CJ; 0000-0001-5645-4966 | |
dc.identifier.name-orcid | Tai, AW; 0000-0002-6877-450X | |
dc.identifier.name-orcid | Sexton, JZ; 0000-0002-9244-5888 | |
dc.identifier.name-orcid | Wobus, CE; 0000-0001-5286-0924 | |
dc.identifier.name-orcid | Emmer, BT; 0000-0001-7365-1021 | |
dc.working.doi | 10.7302/24582 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.